nocodazole has been researched along with Li-Fraumeni Syndrome in 1 studies
Li-Fraumeni Syndrome: Rare autosomal dominant syndrome characterized by mesenchymal and epithelial neoplasms at multiple sites. MUTATION of the p53 tumor suppressor gene, a component of the DNA DAMAGE response pathway, apparently predisposes family members who inherit it to develop certain cancers. The spectrum of cancers in the syndrome was shown to include, in addition to BREAST CANCER and soft tissue sarcomas (SARCOMA); BRAIN TUMORS; OSTEOSARCOMA; LEUKEMIA; and ADRENOCORTICAL CARCINOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nayak, SK | 1 |
| Panesar, PS | 1 |
| Kumar, H | 1 |
1 review available for nocodazole and Li-Fraumeni Syndrome
| Article | Year |
|---|---|
p53-Induced apoptosis and inhibitors of p53.
Topics: Amifostine; Apoptosis; Autoimmune Diseases; Benzothiazoles; Humans; Li-Fraumeni Syndrome; Neurodegen | 2009 |